@article{dc5fd5b77ccf49148f509b9eea18df89,
title = "Reply to: {\textquoteleft}Respiratory harms from vaping: Questions for debate and discussion{\textquoteright}",
author = "Lee, {Wai Kit} and Smith, {Catherine L.} and Gao, {Caroline X.} and Borg, {Brigitte M.} and Kristopher Nilsen and David Brown and Annie Makar and Tom McCrabb and Thompson, {Bruce R.} and Abramson, {Michael J.}",
note = "Funding Information: Department of Health, State Government of Victoria, Grant/Award Number: C3478 Funding Information: None of the authors have accepted funding from the tobacco or vaping industries. Michael J. Abramson holds investigator‐initiated grants from Pfizer, Boehringer‐Ingelheim and Sanofi for unrelated research. He is an investigator on the Varenicline And NIcotine replacement therapy for Smokers admitted to Hospitals (VANISH) trial, which is funded by the Global Research Awards for Nicotine Dependence (GRAND). He has undertaken unrelated consultancies for and received assistance with conference attendance from Sanofi. He has also received a speaker's fee from GlaxoSmithKline. Bruce R. Thompson has received speaker and consulting fees from GSK, Mundipharma, Chiesi and AstraZeneca, all unrelated to the current letter. He is immediate past president and director of the Thoracic Society of Australia and New Zealand. The other authors declare that they have no competing interests to disclose. ",
year = "2022",
month = jan,
doi = "10.1111/resp.14181",
language = "English",
volume = "27",
pages = "96--98",
journal = "Respirology",
issn = "1323-7799",
publisher = "Wiley-Blackwell",
number = "1",
}